<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9010081</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21515</journal-id>
<journal-id journal-id-type="nlm-ta">J Nutr Biochem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Nutr. Biochem.</journal-id>
<journal-title-group>
<journal-title>The Journal of nutritional biochemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0955-2863</issn>
<issn pub-type="epub">1873-4847</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29886183</article-id>
<article-id pub-id-type="pmc">6195483</article-id>
<article-id pub-id-type="doi">10.1016/j.jnutbio.2018.04.004</article-id>
<article-id pub-id-type="manuscript">NIHMS961683</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Nutritional Modulation of the Intestinal Microbiota; Future Opportunities for the Prevention and Treatment of Neuroimmune and Neuroinflammatory Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lombardi</surname>
<given-names>Vincent C.</given-names>
</name>
<!--<email>vlombardi@med.unr.edu</email>-->
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Meirleir</surname>
<given-names>Kenny L.</given-names>
</name>
<!--<email>de.meirleir@telenet.be</email>-->
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Subramanian</surname>
<given-names>Krishnamurthy</given-names>
</name>
<!--<email>ksm400@gmail.com</email>-->
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nourani</surname>
<given-names>Sam M.</given-names>
</name>
<!--<email>samnourani@gmail.com</email>-->
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dagda</surname>
<given-names>Ruben K.</given-names>
</name>
<!--<email>rdagda@med.unr.edu</email>-->
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Delaney</surname>
<given-names>Shannon L.</given-names>
</name>
<!--<email>sld2158@cumc.columbia.edu</email>-->
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palotás</surname>
<given-names>András</given-names>
</name>
<!--<email>palotas@asklepios-med.eu</email>-->
<xref ref-type="aff" rid="A7">g</xref>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Nevada Center for Biomedical Research, University of Nevada, Reno, 1664 N. Virginia St. MS 0552, Reno, NV, 89557, USA</aff>
<aff id="A2">
<label>b</label>University of Nevada, Reno, School of Medicine, Department of Pathology, 1664 N. Virginia St. MS 0357, Reno, NV, 89557, USA</aff>
<aff id="A3">
<label>c</label>University of Nevada, Reno, School of Medicine, Department of Internal Medicine, 1664 N. Virginia St. MS 0357, Reno, NV, 89557, USA</aff>
<aff id="A4">
<label>d</label>Advanced Therapeutic, General Gastroenterology &amp; Hepatology Digestive Health Associates, Reno, NV, USA</aff>
<aff id="A5">
<label>e</label>University of Nevada, Reno, School of Medicine, Department of Pharmacology, 1664 N. Virginia St. MS 0318, Reno, NV, 89557, USA</aff>
<aff id="A6">
<label>f</label>Columbia University, Department of Psychiatry, New York, NY, USA</aff>
<aff id="A7">
<label>g</label>Kazan Federal University, Institute of Fundamental Medicine and Biology, (Volga Region) 18 Kremlyovskaya St., Kazan 420008, Republic of Tatarstan, Russian</aff>
<aff id="A8">
<label>h</label>Asklepios-Med (private medical practice and research center), Kossuth Lajos sgt. 23, Szeged, H-6722, Hungary</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence (Vincent C. Lombardi, Ph.D.), Nevada Center for Biomedical Research, University of Nevada, Reno 1664 N Virginia St, MS 0552, Reno, NV, USA, Tel: +(1)(775)682-8278, Fax: +(1)(775)682-8258, <email>vlombardi@med.unr.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P68">
<bold>Declarations</bold>
</p>
<p id="P69">All authors read and approved the final manuscript. The authors declare that there are no conflicts of interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>61</volume>
<fpage>1</fpage>
<lpage>16</lpage>
<!--elocation-id from pubmed: 10.1016/j.jnutbio.2018.04.004-->
<abstract>
<p id="P1">The gut-brain-axis refers to the bidirectional communication between the enteric nervous system and the central nervous system. Mounting evidence supports the premise that the intestinal microbiota plays a pivotal role in its function and has led to the more common and perhaps more accurate term gut-microbiota-brain axis. Numerous studies have identified associations between an altered microbiome and neuroimmune and neuroinflammatory diseases. In most cases, it is unknown if these associations are cause or effect; notwithstanding, maintaining or restoring homeostasis of the microbiota may represent future opportunities when treating or preventing these diseases. In recent years, several studies have identified the diet as a primary contributing factor in shaping the composition of the gut microbiota, and in turn, the mucosal and systemic immune systems. In this review, we will discuss the potential opportunities and challenges with respect to modifying and shaping the microbiota through diet and nutrition in order to treat or prevent neuroimmune and neuroinflammatory disease.</p>
</abstract>
<kwd-group>
<kwd>Microbiome</kwd>
<kwd>neurocognitive</kwd>
<kwd>gut-microbiota-brain axis</kwd>
<kwd>SCFA</kwd>
<kwd>neurotrophic</kwd>
<kwd>vitamin</kwd>
<kwd>oxidative stress</kwd>
<kwd>polyphenols</kwd>
<kwd>myalgic encephalomyelitis</kwd>
<kwd>Parkinson's disease</kwd>
<kwd>Alzheimer’s Disease</kwd>
<kwd>autism</kwd>
<kwd>multiple sclerosis</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>